What this study is
Simplified from ClinicalTrials.govStudying a wearable ring (Oura Ring) to check how well its overnight data match polysomnography, the standard overnight sleep test, in adults ages 18 to 85.
Read the original summary from ClinicalTrials.gov
The current study intends to collect data from Oura Ring time-locked to ground truth medical sleep diagnostic gold-standard polysomnography (PSG) for product research and development, investigational algorithm validation, and scientific dissemination.
Study details
- Official title
- Oura Ring OA15 Overnight Features Validation
- Sponsor
- Ouraring Inc.
- Conditions
- Healthy Adult · Sleep Apnea
- Enrolling
- 60 people
- Starts
- 2026-08-28
- Est. completion
- 2027-01-31
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years – 85 YearsSex ALLHealthy volunteers AcceptedYou may qualify if
- Healthy sample
- Ages 18-85 y
- Body mass index (BMI) <30 kg/m2
- Self-reported habitual sleep duration of 6-9 hours
- Willing and able to comply with the study requirements
- High risk for mild-to-severe sleep apnea, defined by at least one of the following:; Prior clinical diagnosis of obstructive sleep apnea (OSA); Currently seeking or actively undergoing treatment for sleep apnea (e.g., PAP therapy, oral appliance); Documented apnea-hypopnea index (AHI) ≥5 events/hour from a previous sleep study; Self-reported Habitual sleep duration of 6-9 hours; Willing and able to comply with study requirements
You can't join if
- High risk for mild-to-severe sleep apnea
- Individuals with pacemakers
- Non-English speakers
- Individuals who are unwilling or unable to provide informed consent or comply with study procedures
- Current active illness (e.g., cold, flu, bronchitis, suspected COVID-19)
- Have known allergies or previous reaction to titanium or medical-grade plastic
- Report regularly sleeping <4 hours per night
- Restricted peripheral circulation (e.g. Raynaud's disease)
- Individuals with physical limitations or deformities or skin conditions that would preclude safely wearing up to two Oura Ring devices or reference polysomnography equipment
- Individuals that have completed overnight rotating shift-work in the past 2 weeks
- Individuals that have traveled across time-zones in the past week
- Current use (within the past month) of the following medications/classes, pending investigator decision: Stimulants (Adderall, Ritalin); Sodium oxybate; Heroin, cocaine, or methamphetamines; Non-stimulant wake promoting agents (e.g. modafinil, pitolisant, etc.); Prescription sleep medication
- Individuals employed by a company that develops or sells medical and/or fitness devices in a similar space (e.g. wearables) or are technology journalists (e.g. professional bloggers, TV, magazine, newspaper reporters, etc.) Sleep Apnea sample
- Same as for Healthy Adult sample, with the exception of the "high risk for mild-to-moderate sleep apnea) criterion
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openClayton Sleep Institute Sleep Center
St Louis, Missouri, United States
- Matthew Uhles, MS, RPSGT, RST · Contact314-645-5855 ext. 318uhlesm@claytonsleep.com
Recruiting
Study team
Sponsor
Ouraring Inc.
Study ID OS26HW01
Principal investigator
Joseph Ojile, MD
Clayton Sleep Institute, LLC
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.